Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
The findings of two recent studies published in Cell Host & Microbe may help to develop new diagnostic tools and better animal models of ME/CFS.
The findings of a new study support the ‘sterile womb’ hypothesis and may help scientists avoid pitfalls of contamination in the analysis of samples where microbes are expected to be…
The findings of a new study indicate that gut commensals may contribute to obesity through the overproduction of microbe-derived lipids.
The findings of a new study suggest that biomarkers such as the gut microbiota composition may help develop diagnostics and therapeutic approaches for gestational diabetes.
The immune system tolerates flagellins of commensal bacteria while mounting an immune response against flagellins produced by pathogens.
The findings may inform strategies to modulate the gut microbiota as a way to prevent or treat neurodegeneration.
Vaccines against F. nucleatum and other onco-microbes may help prevent diseases such as colorectal cancer.
The findings of a recent study suggest that the availability of iron can reshape the composition of the gut microbiota in irreversible ways.
The findings of a recent study suggest that the microbiota can promote neuronal repair after tissue damage.
The findings of a recent study may inform dietary interventions to help protect people against type 1 diabetes and other autoimmune diseases.
